Navigation Links
Experimental drug achieves unprecedented weight loss
Date:4/10/2011

959, and topiramate, marketed under the trade name Topamax, in doses up to 400mg to treat epilepsy and prevent migraines. Patients in the study also received diet and exercise advice.

The study was funded by Vivus, which is seeking FDA approval to market the combination therapy under the trade name Qnexa. In October 2010, the FDA ruled that the New Drug Application could not be approved in its current form, and asked the company for more safety data.

In March, the FDA issued a warning regarding the use of topiramate during pregnancy stating that pregnant women who take the drug are at considerably increased risk of having babies born with cleft lip and/or cleft palate. Topiramate has also been associated with memory problems and mood changes, including depression and anxiety.

Gadde says 34 women became pregnant while in Qnexa clinical trials, and "no birth defects were reported for the babies born." Even so, Gadde says pregnant women would not be candidates for use of this drug because "there is no reason for women to use weight loss drugs while they are pregnant or trying to become pregnant."

The study used once-daily oral doses of the combined drugs. Phentermine 7.5mg plus topiramate CR 46mg achieved 7.8 percent weight loss (p<0.0001 vs placebo). Phentermine 15mg plus topiramate CR 92mg achieved 9.8 percent weight loss (p<0.0001 vs placebo). The placebo group experienced 1.2 percent weight loss.

The greatest improvement in cardiovascular disease and diabetes were seen in high risk patients among the groups given placebo, phentermine 7.5mg plus topiramate 40mg, or phentermine 15mg plus topiramate 92mg respectively:

  • Systolic blood pressure: -4.9mmHg, -6.9mmHg, -9.1mmHg
  • Diastolic blood pressure: -3.9mmHg, -5.2mmHg, -5.8mmHg
  • Total cholesterol: -4.9%, -5.7%, -7.8%
  • LDL: -3.6%, 0.7%, -4.3%
  • HDL: 2.8%, 9.5%, 10.7%
  • Triglycerides: -8.8%, -24.1%, -25.6%
  • Hemoglobin A1C in diabetics:
    '/>"/>

Contact: Debbe Geiger
debbe.geiger@duke.edu
919-660-9461
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Science at a glance: Symposia, research and special events at Experimental Biology 2011
2. A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease
3. Extra Tests Not a Deterrent to Experimental Cancer Therapy
4. 2 Experimental Drugs Show Promise for Rare Pancreatic Cancer
5. Experimental approach may improve healing of diabetic wounds and bed sores
6. Study raises safety concerns about experimental cancer approach
7. First liver transplant patients receive experimental drug to prevent hepatitis C infection
8. Experimental Drug Helps Fight Aggressive Breast Cancer: Report
9. Experimental drug more potent, longer lasting than morphine
10. Experimental vaccine sets sights on lung cancer
11. Experimental Drug Raises Good Cholesterol Levels in Early Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Joseph M. Lee, ... Hudson Valley (CDHV), a leading provider of quality cardiovascular ... Hudson Valley. Dr. Lee is a board certified ... , In addition to his position at CDHV, ... New York-Presbyterian Hospital/ Columbia University Medical Center. Dr. Lee ...
(Date:7/31/2014)... Bedford Commons OB-GYN partnered with local growth ... to do what Christina Haag, the practice administrator referred ... all while still offering the greatest service to our ... health needs for every stage of their life – ... Gynecology ), worked diligently with their marketing and strategy ...
(Date:7/31/2014)... 31, 2014 Transvaginal mesh lawsuits ( ... move forward in the federal multidistrict litigation underway in ... Liebhard LLP reports. According to an Order dated July ... defense motions now pending before the Court. The telephonic ... on Tuesday, August 5th at 2:30 p.m. (In re: ...
(Date:7/31/2014)... Live To Be Sober , a no-cost 24/7 ... and program information to people who want to help ... alcohol addiction, proudly announced today that it has entered ... bad boy, gone good. , "NBC's The Voice touched ... whose new single Stomp (#Stomp; available on iTunes ...
(Date:7/31/2014)... London, UK (PRWEB) July 31, 2014 ... in the development and maintenance of products in the ... can be performed by using various products and equipment ... and spoilage of various materials and products. , ... and services is forecast to post a CAGR of ...
Breaking Medicine News(10 mins):Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 3Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 2Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 3Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 2Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 3
... Inc. today will present Phase II clinical data ... next-generation antidepressant, is effective for treating major depressive ... outcome for depression. EB-1010 also improved measures of ... characterized by the inability to experience pleasure. The ...
... , TUESDAY, Dec. 7 (HealthDay News) -- Electronic cigarettes ... University of California researchers say. Their study ... devices that contain nicotine, flavorings and other chemicals. The ... and Drug Administration cited five e-cigarette distributors for poor ...
... pioneering clinical trial is testing the effectiveness in leukemia of ... can disable the well-known tumor suppressor p53. Michael ... Hematology and Therapy in the Department of Leukemia at The ... of this ongoing Phase I study at the 52nd Annual ...
... Madonna Behen HealthDay Reporter , TUESDAY, Dec. ... who suffer concussions may have different symptoms than boys, ... boys are more likely to report amnesia and confusion/disorientation, ... to noise more often. "The take-home message is ...
... A school-based intervention program designed for adolescents with ... life for the students who participate, and reduces ... City, who studied the effect of the program ... The Asthma Self-Management for Adolescents (ASMA) program is ...
... HealthDay Reporter , TUESDAY, Dec. 7 (HealthDay News) -- ... folks because they create a network of close friends ... Conducted at the University of Wisconsin, the researchers found ... say they are "extremely satisfied" with life as opposed ...
Cached Medicine News:Health News:Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting 2Health News:Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting 3Health News:E-Cigarettes Should Be Banned Until Made Safe: Study 2Health News:Small molecule may disarm enemy of cancer-fighting p53 2Health News:Concussion Symptoms Can Differ for Boys and Girls 2Health News:Concussion Symptoms Can Differ for Boys and Girls 3Health News:School-based program helps adolescents cope with asthma 2Health News:School-based program helps adolescents cope with asthma 3Health News:Friends May Be Key to Churchgoers' Happiness 2Health News:Friends May Be Key to Churchgoers' Happiness 3
(Date:7/31/2014)... 2014  Decision Resources Group is launching an extension ... to now include ChinaTrack; the new capabilities track the ... interactive dashboard providing detailed brand-level share tracking and analytics. ... level. Other key capabilities of the new ... addition to end-user surveys of healthcare facilities, ChinaTrack data ...
(Date:7/31/2014)... Portugal , July 31, 2014 ... Cork, Ireland has successfully passed a pre-approval inspection ... The inspection, carried out by the FDA Consumer Safety Officer, ... planned, started on 21 st July and concluded on ... be compliant with the principles and guidelines of Good Manufacturing ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... in New York results of AFF008, ... Parkinson,s disease. PD01A is the first therapy against the protein ... The Michael J. Fox Foundation for Parkinson,s Research ... and presented at the press conference on the impact a ...
Breaking Medicine Technology:Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
... Mich., Feb. 1, 2011 Fiscal second quarter ... million Fiscal second quarter GAAP income from continuing ... per share Fiscal second quarter adjusted income from ... Record second quarter cash flow from operations of ...
... Nephros, Inc. (OTC Bulletin Board: NEPH ), ... for therapeutic applications, infection control, and water purification, today ... its previously announced rights offering to its existing stockholders ... Securities and Exchange Commission. Under the terms ...
Cached Medicine Technology:Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 18Nephros Rights Offering Registration Statement Declared Effective 2Nephros Rights Offering Registration Statement Declared Effective 3Nephros Rights Offering Registration Statement Declared Effective 4
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
... Used as an initial access wire into ... prior to an endourology procedure. The mandril type ... that of a .035 inch (0.89 mm) diameter ... guide is of spring coil construction over the ...
Used over a wire guide for cutting the renal fascia to facilitate dilation of a musculofascial tract. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: